Results 51 to 60 of about 48,929 (237)
In recent years, various devices have been approved for peripheral artery disease with femoropopliteal lesions. However, treatment of long, calcified, and diffused lesions is still challenging because these lesions are associated with restenosis.
Naoki Yoshioka +4 more
doaj +1 more source
The present study was aimed to establish a prediction model for in-stent restenosis (ISR) in subjects who had undergone percutaneous coronary intervention (PCI) with drug-eluting stents (DESs). A retrospective cohort study was conducted.
M. Gai +9 more
semanticscholar +1 more source
Background: For patients with symptomatic intracranial artery stenosis (sICAS), endovascular treatment has been shown to be feasible and safe in recent studies. However, in-stent restenosis (ISR) risks the recurrence of ischemic stroke.
Xu Guo +5 more
semanticscholar +1 more source
'Miracle stents' - a future without restenosis
Over the last three decades, percutaneous coronary intervention (PCI) technology has revolutionized the field of cardiology. PCI began in the form of balloon angioplasty, and was followed by coronary stenting.
Huda Hamid, John Coltart
doaj +1 more source
Background To evaluate the effect of stent compression on in-stent restenosis (ISR) and clinical outcomes in patients with iliac vein compression syndrome (IVCS) after iliac vein stenting.
Yuheng Yang +6 more
semanticscholar +1 more source
A temporally controlled drug release coating is developed for abutments using a superhydrophobic coating self‐assembled on mesoporous silica. This surface provides sequential functionality: initial contamination resistance through non‐wetting, followed by controlled drug release via wettability transition.
Zhongchao Wang +8 more
wiley +1 more source
Stent restenosis, especially the diffuse pattern, has developed into a significant clinical and economical problem. It has been estimated that up to 250,000 patients developed in‐stent restenosis in 2,000 alone, two thirds of them can be expected to have diffuse in‐stent restenosis, which is difficult to treat because of high recurrence rates.
openaire +2 more sources
Biodegradable Zn‐Based Implants: Progress, Challenges, and Pathways toward Clinical Translation
Exploring biodegradable Zn‐based implants offers a promising pathway to next‐generation biomedical devices with balanced degradation and biocompatibility. A comprehensive overview of biodegradable Zn‐based implants, covering their biological significance, material design principles, and advanced engineering strategies is provided.
Panfeng Zhao +10 more
wiley +1 more source
Background After carotid artery angioplasty with stenting (CAS), it is unclear which risk factors are related to long-term outcomes, including in-stent restenosis (ISR).
Sangil Park +5 more
semanticscholar +1 more source
In-stent restenosis and stent compression in iliofemoral venous stents.
Quant Imaging Med Surg 2021 | https://dx.doi.org/10.21037/qims-21-738 I read with great interest the manuscript by Yang et al. (1) that was published recently and wished to congratulate the authors for their excellent management and diagnosis of instent ...
T. Saleem
semanticscholar +1 more source

